Condition deep-dive · 6 min read

Heavy menstrual bleeding — supplement protocol for iron and fatigue

Updated 2026-05-12 · Reviewed by SupplementScore editors · No sponsorships

Heavy menstrual bleeding (HMB, formerly "menorrhagia") affects 20–30% of menstruating women at some point. The clinical consequence that supplements most directly address is iron deficiency and iron-deficiency anemia — the most common nutritional deficiency globally and one with disproportionate impact in HMB. Medical management of the bleeding itself dominates outcomes (hormonal therapy, tranexamic acid, levonorgestrel IUD, surgical options); supplements are an essential adjunct for the iron-fatigue downstream effect, not a substitute for evaluating and treating the underlying bleeding pattern.

Read this first. New-onset, worsening, or perimenopausal heavy bleeding warrants gynaecology evaluation — to rule out fibroids, adenomyosis, polyps, endometrial pathology, coagulopathy (including von Willebrand disease), and (in perimenopause) endometrial hyperplasia or cancer. Heavy bleeding plus easy bruising, family history of bleeding disorders, or post-procedural bleeding should prompt coagulation evaluation. Don't normalise HMB as "just heavy periods" — it has medical causes worth identifying.

The iron repletion strategy

Tier 1 evidence · The dominant supplement intervention

Iron — ferrous bisglycinate (gentle iron) preferred

For deficiency: 60–120 mg elemental iron per dose, often alternate-day dosing is better-absorbed and better-tolerated than daily; clinician guidance is appropriate

Iron deficiency in HMB is treated to first replete hemoglobin (typically over 8–12 weeks) and then continue to restore ferritin to ≥50 ng/mL (or higher if symptomatic) before tapering or discontinuing. Ferrous bisglycinate has better GI tolerability than ferrous sulfate at similar elemental doses. The 2017 Stoffel research established that alternate-day dosing (rather than daily) often produces better total iron absorption because daily dosing transiently elevates hepcidin and blocks subsequent absorption. Avoid taking iron with calcium, coffee, or tea — separate by 2 hours. Vitamin C with the dose modestly improves absorption.

Tier 1 evidence · Absorption cofactor

Vitamin C (moderate dose) with iron dosing

100–250 mg vitamin C with each iron dose

Ascorbic acid reduces ferric (Fe³⁺) iron to absorbable ferrous (Fe²⁺) form in the intestinal lumen and modestly improves iron uptake. The benefit is most relevant with non-heme iron sources (most supplements). Take simultaneously with iron supplement.

Tier 2 evidence · Where deficient

Vitamin B12 and folate

B12: 500–1000 µg/day methylcobalamin oral; Folate: 400–800 µg/day (or higher if planning pregnancy)

Combined B12 and folate deficiency can compound anemia from iron deficiency. Test both with a CBC and reticulocyte count if anemia is mixed-pattern. B12 deficiency is more common with PPI use, metformin use, vegetarian/vegan diets, and atrophic gastritis. Folate deficiency is rare in fortified-food countries but worth ruling out.

Tier 2 evidence · For users on hormonal therapy with B-vitamin depletion patterns

B-complex (low-dose, balanced)

B6 (P5P) 10–25 mg/day, B12 250–500 µg/day, methylated folate 400 µg/day — only if combined OCP use is associated with vitamin depletion symptoms

Combined oral contraceptive use modestly depletes B6, B12, folate, riboflavin, and other B vitamins. A modest B-complex is reasonable adjunct in users on combined OCPs. Avoid high-dose B6 (above 100 mg/day) chronically — peripheral neuropathy risk.

Tier 3 evidence · For users with cyclic mood symptoms

Magnesium glycinate

200–400 mg elemental magnesium daily

Magnesium has modest evidence for cyclic PMS-related mood symptoms and may modestly reduce menstrual cramping. Not specifically for HMB volume reduction.

What about supplements that "reduce bleeding"?

Several supplements are marketed as menstrual-flow-reducing — vitex/chasteberry, raspberry leaf, shepherd's purse, yarrow. The evidence base for HMB volume reduction with these is weak. Tranexamic acid (a prescription antifibrinolytic) is the most-evidenced non-hormonal medical option for reducing menstrual blood loss (typically 25–40% reduction). It outperforms anything in the supplement aisle for this purpose.

What to skip — common but unhelpful or risky

"Iron-free" multivitamins in confirmed iron deficiency — common in over-50 multivitamin formulas because iron overload is the more common concern in that demographic; not appropriate in menstruating women with iron deficiency.
Iron via blood-builder herbal tonics with low elemental iron content — most herbal tonics deliver subclinical iron doses that don't meaningfully treat deficiency.
Iron taken with calcium-containing supplements or food — calcium impairs iron absorption.
Aspirin and NSAID-containing supplements / pain bundles for HMB — these can increase bleeding. Tranexamic acid is the non-hormonal pharmacological option, not OTC analgesics. NSAIDs are acceptable for pain but don't reduce blood loss substantially.
Vitamin E high-dose, garlic high-dose, ginkgo, ginger high-dose — additive antiplatelet effect; theoretically can increase bleeding volume.
"Liver detox" / "estrogen detox" supplements — based on unsupported framing.

The medical layer — where supplements sit alongside

Tranexamic acid (1 g three times daily during menses) — non-hormonal, well-tolerated, reduces blood loss substantially.
NSAIDs (mefenamic acid, naproxen) during menses — modest blood-loss reduction, primarily for pain.
Combined hormonal contraception (pill, patch, ring) — reduces blood loss and provides contraception.
Levonorgestrel IUD (Mirena) — the most effective non-surgical option for HMB; particularly useful when contraception is desired.
Endometrial ablation, hysterectomy — for refractory HMB; coordinated with gynaecology.
Workup for underlying causes — pelvic ultrasound, endometrial biopsy where indicated, coagulation studies, TSH, prolactin.

Practical quick-start. Get evaluated for the cause of HMB if new, worsening, or perimenopausal. Test CBC, ferritin, iron studies, TSH at baseline. Treat iron deficiency with ferrous bisglycinate on alternate-day dosing at 60–120 mg elemental iron, paired with vitamin C 100–250 mg per dose. Treat the bleeding itself medically (tranexamic acid, hormonal therapy, or levonorgestrel IUD as appropriate). Reassess ferritin at 8–12 weeks and at 6 months. Don't rely on supplements to reduce bleeding volume — medical options outperform.

What to track

Cycle length, bleeding duration, and pad/tampon count or menstrual cup volume estimation. Hemoglobin and ferritin at baseline, at 8–12 weeks, and at 6 months. Iron deficiency symptoms (fatigue, hair shedding, restless legs at night, brittle nails, ice craving). Cardiovascular tolerance during physical activity (exercise tolerance is often the most sensitive indicator of subclinical iron deficiency).